BGI Units Lose Appeal Over Illumina DNA Sequencing IP
The Court of Appeal on Friday rejected a bid by BGI Group subsidiaries to overturn findings that they infringed valid patents for rapid DNA sequencing held by Illumina Cambridge Ltd., holding...To view the full article, register now.
Already a subscriber? Click here to view full article